inforMED
MalfunctionCDP

ELECSYS FT3 III

Received Jun 16, 2023 · Event occurred May 22, 2023

Report 1823260-2023-01986 · MDR key 17145120

Device

Generic name

Total Triiodothyronine

Manufacturer

Roche Diagnostics

Model number

NA

Catalog number

09005811190

Lot number

669112

Product problems

  • High Test Results
  • High Test Results

Patient

27 YR · Female

  • No Clinical Signs, Symptoms or Conditions
  • No Clinical Signs, Symptoms or Conditions

Narrative

Additional Manufacturer Narrative

THE PATIENT SAMPLE WAS PROVIDED FOR INVESTIGATION. THE HIGH FT3 VALUE GENERATED AT THE CUSTOMER SITE COULD BE REPRODUCED. FURTHER INVESTIGATIONS DETERMINED THE SAMPLE CONTAINS AN INTERFERING FACTOR AGAINST THE STREPTAVIDIN COMPONENT OF THE FT3 ASSAY. PER PRODUCT LABELING: "IN RARE CASES, INTERFERENCE DUE TO EXTREMELY HIGH TITERS OF ANTIBODIES TO ANALYTE-SPECIFIC ANTIBODIES, STREPTAVIDIN OR RUTHENIUM CAN OCCUR. THESE EFFECTS ARE MINIMIZED BY SUITABLE TEST DESIGN. FOR DIAGNOSTIC PURPOSES, THE RESULTS SHOULD ALWAYS BE ASSESSED IN CONJUNCTION WITH THE PATIENT¿S MEDICAL HISTORY, CLINICAL EXAMINATION AND OTHER FINDINGS." THE INVESTIGATION COULD NOT IDENTIFY A PRODUCT PROBLEM.

Description of Event or Problem

THE INITIAL REPORTER STATED THEY RECEIVED DISCREPANT RESULTS FOR ONE PATIENT SAMPLE TESTED WITH ELECSYS FT3 III VER. 2 (FT3 V2) ASSAY ON MULTIPLE ROCHE ANALYZERS. AN INTERFERENCE IS SUSPECTED. NO INCORRECT RESULTS WERE REPORTED OUTSIDE OF THE LABORATORY. THE SAMPLE WAS COLLECTED ON (B)(6) AND INITIALLY TESTED WITH FT3 V2 ON THE CUSTOMER'S COBAS E 801 MODULE ON AN UNKNOWN DATE. THE SAMPLE WAS TREATED WITH A 25 % POLYETHYLENE GLYCOL (PEG) SOLUTION AND REPEATED ON THE CUSTOMER'S COBAS E 801 MODULE. THE SAMPLE WAS REPEATED USING THE WAKO ACCURASEED FT3 METHOD. THE SAMPLE WAS PROVIDED FOR INVESTIGATION, WHERE IT WAS TESTED WITH THE FT3 V2 ASSAY ON A SECOND E 801 ANALYZER ON 26-MAY-2023. DURING INVESTIGATIONS, THE SAMPLE WAS ALSO TESTED WITH THE FT3 V2 ASSAY ON A COBAS E 411 ANALYZER. THE SAMPLE WAS ALSO REPEATED USING THE ABBOTT ARCHITECT FT3 METHOD ON (B)(6) 2023. REFER TO THE ATTACHMENT FOR ALL RELEVANT PATIENT RESULTS. THE SERIAL NUMBER OF THE CUSTOMER'S E 801 ANALYZER IS UNKNOWN. THE FT3 V2 REAGENT LOT NUMBER AND EXPIRATION DATE USED ON THIS ANALYZER WERE REQUESTED, BUT NOT PROVIDED. THE SERIAL NUMBER OF THE E 801 ANALYZER USED FOR INVESTIGATION IS 14D9-06. FT3 V2 REAGENT LOT NUMBER 669112, WITH AN EXPIRATION DATE OF 28-FEB-2024 WAS USED ON THIS ANALYZER. THE SERIAL NUMBER OF THE E411 ANALYZER USED FOR INVESTIGATION IS 65G1-25. FT3 V2 REAGENT LOT NUMBER 669112, WITH AN EXPIRATION DATE OF 28-FEB-2024 WAS USED ON THIS ANALYZER.

Additional Manufacturer Narrative

THE SAMPLE WAS REQUESTED FOR INVESTIGATION. H3 OTHER TEXT : NA